| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |